Aurora Cannabis Inc. has announced a significant regulatory achievement for its international operations. The company has obtained community plant variety rights for two of its proprietary genetics, consolidating the protection of its cannabis strains in the European Union.

The measure was formalized by the Community Plant Variety Office of the bloc. The grant covers the Farm Gas™ and Sourdough™ strains, which were developed at the company's research and development facilities in Canada.

Legal protection of cannabis strains in the European Union

With the new regulation, the company ensures exclusive control over the commercial production and sale of these genetics. The legal protection covers all 27 member states and will be valid for the period stipulated by the regulatory body for these cannabis strains in the European Union.

"The grant of Community Plant Variety Rights in the EU is a direct recognition of the exceptional cannabis genetics work underway at our leading P&D facility, Aurora Coast," said Lana Culley, Vice President of Innovation and International Operations at Aurora, in a statement.

The now protected genetics are characterized by high potency and distinct aromatic profiles. Currently, these products are already available to medical patients in countries such as Germany, Poland, the United Kingdom, and Australia, in addition to the Canadian market.

Global strategy and financial landscape

The acquisition of these rights is seen as strategic for the global commercialization of the cultivars. The move aims to safeguard the investments made in research, adding to similar intellectual property rights that Aurora already holds for its cannabis strains in the European Union and other territories.

The company's genetic platform underpins its operations in multiple international markets. This includes both its own cultivation sites and distribution through licensed partners around the world.

In the economic scenario, the medical cannabis company is valued at US$238.24 million. Data from InvestingPro indicate that analysts predict the company could achieve profitability in this fiscal year, partly driven by the expansion of its cannabis strains in the European Union.

With information from Investing